BNTX
BioNTech SE
98.50$
-0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 15.1% | 10.7% | 16.0% | 12.3% | 15.3% | 17.3% | 15.7% | 19.7% | 22.4% | |
| 84.9% | 89.3% | 84.0% | 87.7% | 84.7% | 82.7% | 84.3% | 80.3% | 77.6% | |
| 138.8% | 112.1% | 208.6% | 133.7% | 5.0% | 8.9% | 46.7% | 81.9% | 73.3% | |
| 37.2% | 18.8% | 39.1% | 19.8% | 1.5% | 2.8% | 13.0% | 19.3% | 21.3% | |
| 184.4% | 131.5% | 251.1% | 104.8% | 4.1% | 9.7% | 66.2% | 128.1% | 100.3% | |
| -99.5% | -42.2% | -167.1% | -17.1% | 80.5% | 73.0% | 18.1% | -47.8% | -22.6% | |
| 1.1% | 1.4% | 1.6% | 0.4% | 0.0% | 0.1% | 0.2% | 0.5% | 0.5% | |
| -139.5% | -37.4% | -165.2% | -30.2% | 79.3% | 74.8% | 31.1% | -24.6% | -36.6% | |
| 0.1% | 0.5% | -0.2% | -33.4% | 25.1% | 20.3% | 6.7% | -0.5% | 3.0% | |
| -139.1% | -37.6% | -164.9% | 3.2% | 54.2% | 54.5% | 24.4% | -24.2% | -39.6% | |
| -121.3% | -18.8% | -132.4% | -21.8% | 79.1% | 75.7% | 36.1% | -13.3% | -22.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.